Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 4525 entries
Sorted by: Best Match Show Resources per page
Histopathological Features of Methotrexate Induced Pulmonary Lesions in Rheumatoid Arthritis Patients: A Systematic Review of Case Reports.

Open access Macedonian journal of medical sciences

Thaniyan A, Ayman FFA, Mirghani HO, Al-Sayed BA, Merghani TH.
PMID: 28507640
Open Access Maced J Med Sci. 2017 Apr 08;5(2):266-270. doi: 10.3889/oamjms.2017.049. eCollection 2017 Apr 15.

BACKGROUND: Methotrexate (MTX) is the most commonly used disease-modifying drug in the treatment of rheumatoid arthritis (RA); however, it causes many side effects, including pulmonary lesions. In this review, we characterised the histopathological features of MTX-induced pulmonary lesions in...

Cite
Thaniyan A, Ayman FFA, Mirghani HO, et al. Histopathological Features of Methotrexate Induced Pulmonary Lesions in Rheumatoid Arthritis Patients: A Systematic Review of Case Reports. Open Access Maced J Med Sci. 2017;5(2):266-270doi: 10.3889/oamjms.2017.049.
Thaniyan, A., Ayman, F. F. A., Mirghani, H. O., Al-Sayed, B. A., & Merghani, T. H. (2017). Histopathological Features of Methotrexate Induced Pulmonary Lesions in Rheumatoid Arthritis Patients: A Systematic Review of Case Reports. Open access Macedonian journal of medical sciences, 5(2), 266-270. https://doi.org/10.3889/oamjms.2017.049
Thaniyan, Anthony, et al. "Histopathological Features of Methotrexate Induced Pulmonary Lesions in Rheumatoid Arthritis Patients: A Systematic Review of Case Reports." Open access Macedonian journal of medical sciences vol. 5,2 (2017): 266-270. doi: https://doi.org/10.3889/oamjms.2017.049
Thaniyan A, Ayman FFA, Mirghani HO, Al-Sayed BA, Merghani TH. Histopathological Features of Methotrexate Induced Pulmonary Lesions in Rheumatoid Arthritis Patients: A Systematic Review of Case Reports. Open Access Maced J Med Sci. 2017 Apr 08;5(2):266-270. doi: 10.3889/oamjms.2017.049. eCollection 2017 Apr 15. PMID: 28507640; PMCID: PMC5420786.
Copy Download .nbib Format: NLM
Metabolic parameters in psoriatic patients treated with interleukin-12/23 blockade (ustekinumab).

The Journal of dermatology

Ng CY, Tzeng IS, Liu SH, Chang YC, Huang YH.
PMID: 28980716
J Dermatol. 2018 Mar;45(3):309-313. doi: 10.1111/1346-8138.14079. Epub 2017 Oct 05.

The associations between psoriasis, metabolic syndrome and cardiovascular events are increasingly recognized. Studies have shown decreased cardiovascular events with the treatment of methotrexate and anti-tumor necrosis factor, however, effects of interleukin (IL)-12/23 blockade remain debatable. Our study investigated the...

Cite
Ng CY, Tzeng IS, Liu SH, et al. Metabolic parameters in psoriatic patients treated with interleukin-12/23 blockade (ustekinumab). J Dermatol. 2017;45(3):309-313doi: 10.1111/1346-8138.14079.
Ng, C. Y., Tzeng, I. S., Liu, S. H., Chang, Y. C., & Huang, Y. H. (2018). Metabolic parameters in psoriatic patients treated with interleukin-12/23 blockade (ustekinumab). The Journal of dermatology, 45(3), 309-313. https://doi.org/10.1111/1346-8138.14079
Ng, Chau Yee, et al. "Metabolic parameters in psoriatic patients treated with interleukin-12/23 blockade (ustekinumab)." The Journal of dermatology vol. 45,3 (2018): 309-313. doi: https://doi.org/10.1111/1346-8138.14079
Ng CY, Tzeng IS, Liu SH, Chang YC, Huang YH. Metabolic parameters in psoriatic patients treated with interleukin-12/23 blockade (ustekinumab). J Dermatol. 2018 Mar;45(3):309-313. doi: 10.1111/1346-8138.14079. Epub 2017 Oct 05. PMID: 28980716.
Copy Download .nbib Format: NLM
Placental site trophoblastic tumor presenting as an intramural mass with negative markers: an opportunity for novel diagnosis and treatment with robotic hysterectomy.

Journal of robotic surgery

Namaky D, Basil J, Pavelka J.
PMID: 27638575
J Robot Surg. 2010 May;4(1):57-9. doi: 10.1007/s11701-010-0178-y. Epub 2010 Mar 18.

A patient presented with persistent levels of quantitative human chorionic gonadotropin despite therapy with methotrexate. A dilation and curettage procedure did not provide a pathologic diagnosis. Gestational trophoblastic disease was suspected, but serum biomarkers were unable to provide a...

Cite
Namaky D, Basil J, Pavelka J. Placental site trophoblastic tumor presenting as an intramural mass with negative markers: an opportunity for novel diagnosis and treatment with robotic hysterectomy. J Robot Surg. 2010;4(1):57-9doi: 10.1007/s11701-010-0178-y.
Namaky, D., Basil, J., & Pavelka, J. (2010). Placental site trophoblastic tumor presenting as an intramural mass with negative markers: an opportunity for novel diagnosis and treatment with robotic hysterectomy. Journal of robotic surgery, 4(1), 57-9. https://doi.org/10.1007/s11701-010-0178-y
Namaky, Devin, et al. "Placental site trophoblastic tumor presenting as an intramural mass with negative markers: an opportunity for novel diagnosis and treatment with robotic hysterectomy." Journal of robotic surgery vol. 4,1 (2010): 57-9. doi: https://doi.org/10.1007/s11701-010-0178-y
Namaky D, Basil J, Pavelka J. Placental site trophoblastic tumor presenting as an intramural mass with negative markers: an opportunity for novel diagnosis and treatment with robotic hysterectomy. J Robot Surg. 2010 May;4(1):57-9. doi: 10.1007/s11701-010-0178-y. Epub 2010 Mar 18. PMID: 27638575.
Copy Download .nbib Format: NLM
The paediatric rheumatologist and orphan disease - a story without happy ending.

Reumatologia

Roszkiewicz J, Biernacka-Zielińska M, Smolewska E.
PMID: 27504025
Reumatologia. 2016;54(3):141-5. doi: 10.5114/reum.2016.61216. Epub 2016 Jul 18.

Orphan diseases are not a common challenge in the everyday practice of the rheumatologist. Despite their extremely rare occurrence one of the patients under our care developed one of them - neuronal ceroid lipofuscinosis, the most frequent neurodegenerative disease...

Cite
Roszkiewicz J, Biernacka-Zielińska M, Smolewska E. The paediatric rheumatologist and orphan disease - a story without happy ending. Reumatologia. 2016;54(3):141-5doi: 10.5114/reum.2016.61216.
Roszkiewicz, J., Biernacka-Zielińska, M., & Smolewska, E. (2016). The paediatric rheumatologist and orphan disease - a story without happy ending. Reumatologia, 54(3), 141-5. https://doi.org/10.5114/reum.2016.61216
Roszkiewicz, Justyna, et al. "The paediatric rheumatologist and orphan disease - a story without happy ending." Reumatologia vol. 54,3 (2016): 141-5. doi: https://doi.org/10.5114/reum.2016.61216
Roszkiewicz J, Biernacka-Zielińska M, Smolewska E. The paediatric rheumatologist and orphan disease - a story without happy ending. Reumatologia. 2016;54(3):141-5. doi: 10.5114/reum.2016.61216. Epub 2016 Jul 18. PMID: 27504025; PMCID: PMC4967982.
Copy Download .nbib Format: NLM
Uncommon local reaction at the injection site of subcutaneous methotrexate.

Rheumatology (Oxford, England)

Fustà X, Combalia A, Guañabens N, Iranzo P.
PMID: 28977570
Rheumatology (Oxford). 2017 Jul 11; doi: 10.1093/rheumatology/kex264. Epub 2017 Jul 11.

No abstract available.

Cite
Fustà X, Combalia A, Guañabens N, et al. Uncommon local reaction at the injection site of subcutaneous methotrexate. Rheumatology (Oxford). 2017;doi: 10.1093/rheumatology/kex264.
Fustà, X., Combalia, A., Guañabens, N., & Iranzo, P. (2017). Uncommon local reaction at the injection site of subcutaneous methotrexate. Rheumatology (Oxford, England), . https://doi.org/10.1093/rheumatology/kex264
Fustà, Xavier, et al. "Uncommon local reaction at the injection site of subcutaneous methotrexate." Rheumatology (Oxford, England) vol. (2017). doi: https://doi.org/10.1093/rheumatology/kex264
Fustà X, Combalia A, Guañabens N, Iranzo P. Uncommon local reaction at the injection site of subcutaneous methotrexate. Rheumatology (Oxford). 2017 Jul 11; doi: 10.1093/rheumatology/kex264. Epub 2017 Jul 11. PMID: 28977570.
Copy Download .nbib Format: NLM
The Temporal Relationship between Arterial Stiffening and Blood Pressure Is Modified by Methotrexate Treatment in Patients with Rheumatoid Arthritis.

Frontiers in physiology

Woodman RJ, Baghdadi LR, Shanahan ME, Mangoni AA.
PMID: 28861004
Front Physiol. 2017 Aug 15;8:593. doi: 10.3389/fphys.2017.00593. eCollection 2017.

No abstract available.

Cite
Woodman RJ, Baghdadi LR, Shanahan ME, et al. The Temporal Relationship between Arterial Stiffening and Blood Pressure Is Modified by Methotrexate Treatment in Patients with Rheumatoid Arthritis. Front Physiol. 2017;8:593doi: 10.3389/fphys.2017.00593.
Woodman, R. J., Baghdadi, L. R., Shanahan, M. E., & Mangoni, A. A. (2017). The Temporal Relationship between Arterial Stiffening and Blood Pressure Is Modified by Methotrexate Treatment in Patients with Rheumatoid Arthritis. Frontiers in physiology, 8593. https://doi.org/10.3389/fphys.2017.00593
Woodman, Richard J, et al. "The Temporal Relationship between Arterial Stiffening and Blood Pressure Is Modified by Methotrexate Treatment in Patients with Rheumatoid Arthritis." Frontiers in physiology vol. 8 (2017): 593. doi: https://doi.org/10.3389/fphys.2017.00593
Woodman RJ, Baghdadi LR, Shanahan ME, Mangoni AA. The Temporal Relationship between Arterial Stiffening and Blood Pressure Is Modified by Methotrexate Treatment in Patients with Rheumatoid Arthritis. Front Physiol. 2017 Aug 15;8:593. doi: 10.3389/fphys.2017.00593. eCollection 2017. PMID: 28861004; PMCID: PMC5559508.
Copy Download .nbib Format: NLM
Aseptic abscess syndrome associated with traveler's diarrhea after a trip to Malaysia.

IDCases

Panos Z, Giannopoulos G, Papangeli E, Antalis E, Pavli A, Spathis A, Poulakou G, Dimitriadis G, Panayiotides I, Boumpas D, Tsiodras S.
PMID: 27672562
IDCases. 2016 Sep 15;6:23-5. doi: 10.1016/j.idcr.2016.09.001. eCollection 2016.

The first, to our knowledge, case of the aseptic abscesses syndrome as a complication of traveler's diarrhea after a trip to Malaysia is presented. The patient failed to respond to several antimicrobials. The diagnosis was histologically confirmed and the...

Cite
Panos Z, Giannopoulos G, Papangeli E, et al. Aseptic abscess syndrome associated with traveler's diarrhea after a trip to Malaysia. IDCases. 2016;6:23-5doi: 10.1016/j.idcr.2016.09.001.
Panos, Z., Giannopoulos, G., Papangeli, E., Antalis, E., Pavli, A., Spathis, A., Poulakou, G., Dimitriadis, G., Panayiotides, I., Boumpas, D., & Tsiodras, S. (2016). Aseptic abscess syndrome associated with traveler's diarrhea after a trip to Malaysia. IDCases, 623-5. https://doi.org/10.1016/j.idcr.2016.09.001
Panos, Zois, et al. "Aseptic abscess syndrome associated with traveler's diarrhea after a trip to Malaysia." IDCases vol. 6 (2016): 23-5. doi: https://doi.org/10.1016/j.idcr.2016.09.001
Panos Z, Giannopoulos G, Papangeli E, Antalis E, Pavli A, Spathis A, Poulakou G, Dimitriadis G, Panayiotides I, Boumpas D, Tsiodras S. Aseptic abscess syndrome associated with traveler's diarrhea after a trip to Malaysia. IDCases. 2016 Sep 15;6:23-5. doi: 10.1016/j.idcr.2016.09.001. eCollection 2016. PMID: 27672562; PMCID: PMC5035335.
Copy Download .nbib Format: NLM
Tongue Necrosis Secondary to Giant Cell Arteritis: A Case Report and Literature Review.

Case reports in medicine

Sobrinho RABS, de Lima KCA, Moura HC, Araújo MM, de Assis CMRB, Gouveia PADC.
PMID: 28424735
Case Rep Med. 2017;2017:6327437. doi: 10.1155/2017/6327437. Epub 2017 Mar 23.

Giant cell arteritis is a form of vasculitis involving the medium- and large-sized arteries that chiefly affects older people. Clinical findings are headache, jaw claudication, fever, pain, and thickening of the temporal artery. The most feared complication is visual...

Cite
Sobrinho RABS, de Lima KCA, Moura HC, et al. Tongue Necrosis Secondary to Giant Cell Arteritis: A Case Report and Literature Review. Case Rep Med. 2017;2017:6327437doi: 10.1155/2017/6327437.
Sobrinho, R. A. B. S., de Lima, K. C. A., Moura, H. C., Araújo, M. M., de Assis, C. M. R. B., & Gouveia, P. A. D. C. (2017). Tongue Necrosis Secondary to Giant Cell Arteritis: A Case Report and Literature Review. Case reports in medicine, 20176327437. https://doi.org/10.1155/2017/6327437
Sobrinho, Rafael Alex Barbosa de Siqueira, et al. "Tongue Necrosis Secondary to Giant Cell Arteritis: A Case Report and Literature Review." Case reports in medicine vol. 2017 (2017): 6327437. doi: https://doi.org/10.1155/2017/6327437
Sobrinho RABS, de Lima KCA, Moura HC, Araújo MM, de Assis CMRB, Gouveia PADC. Tongue Necrosis Secondary to Giant Cell Arteritis: A Case Report and Literature Review. Case Rep Med. 2017;2017:6327437. doi: 10.1155/2017/6327437. Epub 2017 Mar 23. PMID: 28424735; PMCID: PMC5382308.
Copy Download .nbib Format: NLM
Serum levels of anti-CCP antibodies, anti-MCV antibodies and RF IgA in the follow-up of patients with rheumatoid arthritis treated with rituximab.

Auto- immunity highlights

Fabris M, De Vita S, Blasone N, Visentini D, Pezzarini E, Pontarini E, Fabro C, Quartuccio L, Mazzolini S, Curcio F, Tonutti E.
PMID: 26000112
Auto Immun Highlights. 2010 Nov 04;1(2):87-94. doi: 10.1007/s13317-010-0013-5. eCollection 2010 Nov.

Rheumatoid arthritis (RA) is characterized by the presence of circulating rheumatoid factor (RF) and anticitrullinated peptide antibodies (ACPA), which are positive in about 70-80% of patients. APCA have a higher specificity and therefore a higher diagnostic power than RF,...

Cite
Fabris M, De Vita S, Blasone N, et al. Serum levels of anti-CCP antibodies, anti-MCV antibodies and RF IgA in the follow-up of patients with rheumatoid arthritis treated with rituximab. Auto Immun Highlights. 2010;1(2):87-94doi: 10.1007/s13317-010-0013-5.
Fabris, M., De Vita, S., Blasone, N., Visentini, D., Pezzarini, E., Pontarini, E., Fabro, C., Quartuccio, L., Mazzolini, S., Curcio, F., & Tonutti, E. (2010). Serum levels of anti-CCP antibodies, anti-MCV antibodies and RF IgA in the follow-up of patients with rheumatoid arthritis treated with rituximab. Auto- immunity highlights, 1(2), 87-94. https://doi.org/10.1007/s13317-010-0013-5
Fabris, Martina, et al. "Serum levels of anti-CCP antibodies, anti-MCV antibodies and RF IgA in the follow-up of patients with rheumatoid arthritis treated with rituximab." Auto- immunity highlights vol. 1,2 (2010): 87-94. doi: https://doi.org/10.1007/s13317-010-0013-5
Fabris M, De Vita S, Blasone N, Visentini D, Pezzarini E, Pontarini E, Fabro C, Quartuccio L, Mazzolini S, Curcio F, Tonutti E. Serum levels of anti-CCP antibodies, anti-MCV antibodies and RF IgA in the follow-up of patients with rheumatoid arthritis treated with rituximab. Auto Immun Highlights. 2010 Nov 04;1(2):87-94. doi: 10.1007/s13317-010-0013-5. eCollection 2010 Nov. PMID: 26000112; PMCID: PMC4389048.
Copy Download .nbib Format: NLM
Improved pharmacy department workflow with new method of order entry for single-agent, high-dose methotrexate.

Hospital pharmacy

Kintzel PE, VanDyke TH, Athmann PW, Mills LB, Bonter MP, Bremer MW, Dougherty ML, Foster RW, Knight SK, Slot MG, Steinmetz-Malato LL.
PMID: 25673893
Hosp Pharm. 2014 Dec;49(11):1039-43. doi: 10.1310/hjp4911-1039.

PURPOSE: To determine whether a process change impacted the proportion of orders for single-agent, high-dose methotrexate entered by chemotherapy pharmacists instead of general pharmacy staff. Coordination of antiemetic premedication and leucovorin rescue with the new method of order entry...

Cite
Kintzel PE, VanDyke TH, Athmann PW, et al. Improved pharmacy department workflow with new method of order entry for single-agent, high-dose methotrexate. Hosp Pharm. 2014;49(11):1039-43doi: 10.1310/hjp4911-1039.
Kintzel, P. E., VanDyke, T. H., Athmann, P. W., Mills, L. B., Bonter, M. P., Bremer, M. W., Dougherty, M. L., Foster, R. W., Knight, S. K., Slot, M. G., & Steinmetz-Malato, L. L. (2014). Improved pharmacy department workflow with new method of order entry for single-agent, high-dose methotrexate. Hospital pharmacy, 49(11), 1039-43. https://doi.org/10.1310/hjp4911-1039
Kintzel, Polly E, et al. "Improved pharmacy department workflow with new method of order entry for single-agent, high-dose methotrexate." Hospital pharmacy vol. 49,11 (2014): 1039-43. doi: https://doi.org/10.1310/hjp4911-1039
Kintzel PE, VanDyke TH, Athmann PW, Mills LB, Bonter MP, Bremer MW, Dougherty ML, Foster RW, Knight SK, Slot MG, Steinmetz-Malato LL. Improved pharmacy department workflow with new method of order entry for single-agent, high-dose methotrexate. Hosp Pharm. 2014 Dec;49(11):1039-43. doi: 10.1310/hjp4911-1039. PMID: 25673893; PMCID: PMC4319804.
Copy Download .nbib Format: NLM
[No title available]

Journal of medical biochemistry

Jenko B, Praprotnik S, Tomšic M, Dolžan V.
PMID: 28356883
J Med Biochem. 2016 Sep;35(3):319-323. doi: 10.1515/jomb-2016-0008. Epub 2016 Jul 06.

BACKGROUND: The activation of NLRP3-inflammasome may contribute to inflammatory processes in rheumatoid arthritis (RA). Functional polymorphisms in the genes coding for its components NLRP3 and CARD8 were associated with a proinflammatory phenotype. Our aim was to investigate the influence...

Cite
Jenko B, Praprotnik S, Tomšic M, et al. . J Med Biochem. 2016;35(3):319-323doi: 10.1515/jomb-2016-0008.
Jenko, B., Praprotnik, S., Tomšic, M., & Dolžan, V. (2016). . Journal of medical biochemistry, 35(3), 319-323. https://doi.org/10.1515/jomb-2016-0008
Jenko, Barbara, et al. "." Journal of medical biochemistry vol. 35,3 (2016): 319-323. doi: https://doi.org/10.1515/jomb-2016-0008
Jenko B, Praprotnik S, Tomšic M, Dolžan V. . J Med Biochem. 2016 Sep;35(3):319-323. doi: 10.1515/jomb-2016-0008. Epub 2016 Jul 06. PMID: 28356883; PMCID: PMC5346810.
Copy Download .nbib Format: NLM
Human antigen R as a predictive marker for response to gemcitabine-based chemotherapy in advanced cisplatin-resistant urothelial cancer.

Oncology letters

Miyata Y, Mitsunari K, Akihiro A, Watanabe SI, Matsuo T, Ohba K, Sakai H.
PMID: 28356963
Oncol Lett. 2017 Feb;13(2):811-818. doi: 10.3892/ol.2016.5484. Epub 2016 Dec 12.

In patients with advanced urothelial cancer (UC), a combination of cisplatin (CDDP) and gemcitabine (GEM) is the most commonly used first-line systematic chemotherapy regimen. Although no standard regime for the treatment of CDDP-resistant UC has been established, GEM-based regimens...

Cite
Miyata Y, Mitsunari K, Akihiro A, et al. Human antigen R as a predictive marker for response to gemcitabine-based chemotherapy in advanced cisplatin-resistant urothelial cancer. Oncol Lett. 2016;13(2):811-818doi: 10.3892/ol.2016.5484.
Miyata, Y., Mitsunari, K., Akihiro, A., Watanabe, S. I., Matsuo, T., Ohba, K., & Sakai, H. (2017). Human antigen R as a predictive marker for response to gemcitabine-based chemotherapy in advanced cisplatin-resistant urothelial cancer. Oncology letters, 13(2), 811-818. https://doi.org/10.3892/ol.2016.5484
Miyata, Yasuyoshi, et al. "Human antigen R as a predictive marker for response to gemcitabine-based chemotherapy in advanced cisplatin-resistant urothelial cancer." Oncology letters vol. 13,2 (2017): 811-818. doi: https://doi.org/10.3892/ol.2016.5484
Miyata Y, Mitsunari K, Akihiro A, Watanabe SI, Matsuo T, Ohba K, Sakai H. Human antigen R as a predictive marker for response to gemcitabine-based chemotherapy in advanced cisplatin-resistant urothelial cancer. Oncol Lett. 2017 Feb;13(2):811-818. doi: 10.3892/ol.2016.5484. Epub 2016 Dec 12. PMID: 28356963; PMCID: PMC5351343.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 4525 entries